Idiopathic Pulmonary Fibrosis Clinical Trials
A listing of Idiopathic Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 114 clinical trials
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
For all genders
-
Currently Recruiting
Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
- 2074 views
- 08 Nov, 2020
- 1 location
-
Accepting Seniors
-
Accepting adults
-
For all genders
-
Rare Diseases and Disorders
-
Currently Recruiting
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease that becomes worse over time. There is currently no effective treatment for it. Researchers
- 162 views
- 23 Nov, 2020
- 1 location
-
Phase 3 trial
-
Accepting pediatric ages
-
Accepting adults
-
For all genders
-
Currently Recruiting
A 24-week, double-blind, randomized, parallel-group study evaluating the efficacy and safety of oral nintedanib coadministered with oral sildenafil, compared to treatment with nintedanib alone, in patients with idiopathic pulmonary fibrosis (IPF) and advanced lung function impairment
patients with idiopathic pulmonary fibrosis (IPF) and advanced lung function impairment
- 1316 views
- 23 Nov, 2020
- 1 location
-
Phase 3 trial
-
Accepting pediatric ages
-
1000s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
A Trial to Assess the Safety Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India
of Rotarix/placebo PO at monthly intervals starting at 6 to <8 weeks of age, administered concomitantly with EPI/UIP vaccines. To maintain the blind, infants allocated to the TV P2-VP8 vaccine arm
- 0 views
- 11 Apr, 2021
- 1 location
-
Phase 4 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Management of Progressive Disease in Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a prototype of chronic, progressive, and fibrotic lung disease. It has been considered rare, with an incidence estimated to 11.5 cases per 100 000
- 0 views
- 26 Jan, 2021
- 1 location
-
Multi-country trial
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Rare Diseases and Disorders
-
Currently Recruiting
Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Pulmonary Fibrosis
- 0 views
- 03 Feb, 2021
- 10 locations
-
Multi-country trial
-
Phase 2 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Rare Diseases and Disorders
-
Currently Recruiting
A Study to Test the Efficacy and Safety of Inhaled TD139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
This is a randomized, double-blind, placebo-controlled phase 2b trial in subjects with IPF (idiopathic pulmonary fibrosis) investigating the efficacy and safety of TD139.
- 384 views
- 15 Feb, 2021
- 132 locations
-
Multi-country trial
-
Phase 2 trial
-
Accepting Seniors
-
Accepting adults
-
10s of participants
-
An interventional trial
-
For all genders
-
Rare Diseases and Disorders
-
Currently Recruiting
Safety Efficacy and Pharmacokinetics of C21 in Subjects With IPF
This trial is a multi-centre, open-label, single-arm phase 2 trial investigating the safety, efficacy and pharmacokinetics of C21 in subjects with idiopathic pulmonary fibrosis.
- 0 views
- 04 Apr, 2021
- 20 locations
-
Multi-country trial
-
Phase 2 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Rare Diseases and Disorders
-
Currently Recruiting
A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
This study is open to adults with idiopathic pulmonary fibrosis (IPF) who are at least 40 years old. People taking standard medicines for IPF, including antifibrotic medicines, can continue
- 0 views
- 11 Apr, 2021
- 58 locations
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
High Intensity Interval Training in Fibrotic Interstitial Lung Disease
The fibrotic interstitial lung diseases (fILD) is a group of debilitating chronic lung conditions that are characterised by scarring of lung tissue, dyspnoea on exertion and significant physical impairment. Exercise training is recommended for people with fILD in improving breathlessness and exercise tolerance. However, despite the best efforts of patients …
- 7 views
- 09 Mar, 2021
- 4 locations